G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

Sponsor
National Cancer Institute, Naples
Study ID
NCT00401609
Phase
PHASE1/PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • gemcitabine — DRUG
  • vinorelbine — DRUG
  • cisplatin — DRUG
  • etoposide — DRUG
  • carboplatin — DRUG

Study Details

The purpose of this study is to describe the activity and toxicity of gemcitabine combined with four different drugs (carboplatin or cisplatin or etoposide or vinorelbine) as first line treatment of elderly patients with extensive small cell lung cancer.

Key Dates

Start date
Nov 30, 2000
Status verified
Jan 2016
Primary completion
Dec 31, 2007
Completion
Feb 28, 2009

Study Design

Enrollment
85 participants
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

to evaluate activity and toxicity of GEMVIN combination

Related Studies